Altered Sphingolipid metabolism in Vernal Keratoconjunctivitis: Newer Insights.Menta Vignesh(Madras Diabetes Research Foundation), Narayanasamy Angayarkanni(Sankara Nethralaya)UnknownJanuary 30, 202410.22541/au.170664878.85867083/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersOxidized LDL, homocysteine, homocysteine thiolactone and advanced glycation end products act as pro-oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic effect in ARPE-19 cells|PLoS ONE|2019|39Homocysteine promotes scavenger receptor CD36 mediated oxLDL uptake eliciting PON2 antioxidant defense response in ARPE-19 and THP-1 macrophage cells|Research Square|2022|1Altered Sphingolipid metabolism in Vernal Keratoconjunctivitis: Newer Insights|Unknown|2024|1